IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules

Journal of Immunology

Volumn 172, Issue 10, 2004, Pages 5957-5966

  Terme, Magali ^a   Tomasello, Elena ^b   Maruyama, Koji ^a   Crépineau, Florent ^a   Chaput, Nathalie ^a   Flament, Caroline ^a   Marolleau, Jean Pierre ^c   Angevin, Eric ^a   Wagner, Erwin F ^d   Salomon, Benoît ^e   Lemonnier, François A ^f   Wakasugi, Hiro ^g   Colonna, Marco ^h   Vivier, Eric ^b   Zitvogel, Laurence ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY OF VIENNA   (Austria)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSTITUT PASTEUR   (France)

^g NATIONAL CANCER CENTER   (Japan)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CULTURE MEDIUM; DENDRITIC CELL; FEMALE; GENE TARGETING; IMMUNE RESPONSE; INFLAMMATION; LYMPH NODE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 2442477455     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.10.5957     Document Type: Article

References (63)

1. Inaba, K., and R. M. Steinman. 1985. Protein-specific helper T lymphocyte formation initiated by dendritic cells. Science 229:475.
2. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495.
3. Banchereau J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
4. Schüler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526.
5. Ikarashi, Y., R. Mikami, A. Bendelac, M. Terme, N. Chaput, M. Terada, T. Tursz, E. Angevin, F. A. Lemonnier, H. Wakasugi, and L. Zitvogel. 2001. Dendritic cell maturation overrules H-2D-mediated NKT cell inhibition: a critical role of B7 in CD1d-dependent NKT cell Th1 polarization. J. Exp. Med. 194:1179.
6. + cell derived NK cell cytotoxicity by DC. J. Immunol. 166:1590.
7. + blood DC enhance NK cell mediated cytotoxicity. Eur. J. Immunol. 31:2633.
8. + accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J. Exp. Med. 164:180.
9. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: a cross-talk relevant in innate antitumor immune responses in vivo. Nat. Med. 5:405.
10. Piccioli, D., S. Sbran, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:335.
11. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343.
12. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327.
13. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Erp. Med. 195:F9.
14. Fernandez, N. C., C. Flament, F. Crepineau, E. Angevin, E. Vivier, and L. Zitvogel. 2002. Dendritic cells promote natural killer cell functions: dynamics of the human DC/NK cell cross talk. Eur. Cytokine Network 13:17.
15. + mature DC in human lymph node versus chronically inflamed skin. J. Pathol. 199:98.
16. Ensminger, S. M., B. M. Spriewald, H. V. Sorensen, O. Witzke, E. G. Flashman, A. Bushell, P. I. Morris, M. L. Rose, A. Rahemtulla, and K. I. Wood. 2001. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation. J. Immunol. 167:532.
17. -/- mice. Arterioscler. Thromb. Vasc. Biol. 22:456.
18. Spencer, D. M., G. M. Veldman, S. Banerjee, J. Willis, and A. D. Levine. 2002. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122:94.
19. Elbe-Burger, A., A. Egyed, S. Olt, R. Klubal, U. Mann, K. Rappersberger, A. Rot, and G. Stingl. 2002. Overexpression of IL-4 alters the homeostasis in the skin. J. Invest. Dermatol. 118:767.
20. Kodera, T., T. L. McGaha, R. Phelps, W. E. Paul, and C. A. Bona. 2002. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc. Natl. Acad. Sci. USA 99:3800.
21. Mantovani, A., P. A. Gray, J. Van Damme, and S. Sozzani. 2000. Macrophage-derived chemokine (MDC). J. Leukocyte Biol. 68:400.
22. Greaves, D. R., T. Hakkinen, A. D. Lucas, K. Liddiard, E. Jones, C. M. Quinn, J. Senaratne, F. R. Green, K. Tyson, J. Boyle, et al. 2001. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arteriosler. Thromb. Vasc. Biol. 21:923.
23. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray. 1997. Human macrophage-derived chemokine (MDC) a novel chemoattractant for monocytes, monocyte-derived dendritic cells and natural killer cells. J. Exp. Med. 185:1595.
24. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2000. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, and 1-309. J. Immunol. 164:4048.
25. Guo, J., B. Wang, M. Zhang, T. Chen, Y. Yu, E. Regulier, H. E. Homann, Z. Qin, D. W. Ju, and X. Cao. 2002. Macrophage-derived chemokine gene transfer results in tumor regression murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther. 71:941.
26. Lai, Y. H., J. M. Heslan, S. Poppema, J. F. Elliot, and T. R. Mosmann. 1996. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 156:3166.
27. Zou, W., A. Coulomb, A. Venet, A. Foussat, D. Berrebi, C. Beyer, M. C. Crevon, A. Minty, A. Couedel-Courteille, E. Vivier, et al. 1998. Administration of interleukin-13 to simian immunodeficiency virus-infected macaques: induction of intestinal epithelial atrophy. AIDS Res. Hum Retroviruses 14:775.
28. Tomasello, E., P. O. Desmoulins, K. Chemin, S. Guia, H. Cremer, J. Ortaldo, P. Love, D. Kaiserlian, and E. Vivier. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss of function mutant mice. Immunity 13:355.
29. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
30. Mayordomo, J. I., D. J. Loftus, H. Sakamoto, C. M. De Cesare, P. M. Appasamy, M. T. Lotze, W. J. Storkus, E. AppeUa, and A. B. DeLeo. 1996. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183:1357.
31. Bouchon, A., J. Dietrich, and M. Colonna. 2000. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164:4991.
32. Bouchon, A., C. Hernandez-Munain, M. Cella, and M. Colonna. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111.
33. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
34. Geldhof, A. B., G. Raes, M. Bakkus, S. Devos, K. Thielemans, and P. De Baetselier. 1995. Expression of B7.1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 55:2730.
35. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197.
36. Bakker, A. B., R. M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345.
37. Daws, M. R., L. L. Lanier, W. E. Seaman, and J. C. Ryan. 2001. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur. J. Immunol. 31:783.
38. Bakker, A., E. Baker, G. R. Sutherland, J. H. Phillips, and L. L. Lanier. 1999. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. USA 96:9792.
39. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701.
40. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimuladng factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
41. Labeur, M. S., B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168.
42. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, M. D. Garcia-Prats, A. B. DeLeo, and M. T. Lotze. 1997. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based vaccines. Stem Cells 15:94.
43. Hochrein, H., M. O'Keeffe, T. Luft, S. Vandenabeele, R. J. Grumont, E. Maraskovsky, and K. Shortman. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823.
44. Rougier, N., D. Schmitt, and C. Vincent. 1998. IL-4 addition during differentiation of CD34 progenitors delays maturation of dendritic cells while promoting their survival. Eur. J. Cell Biol. 75:287.
45. + dendritic cell precursors. J. Leukocyte Biol. 64:235.
46. Basak, S. K., A. Harui, M. Stolina, S. Sharma, K. Mitani, S. M. Dubinett, and M. D. Roth. 2002. Increased dendritic cell number following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99:2869.
47. + cells in cancer patients. Cancer Res. 60:1934.
48. Gunji, Y., M. Tagawa, H. Matsubara, K. Takenaga, H. Shimada, F. Kondo, T. Suzuki, K. Nakajima, M. Sugaya, T. Asano, et al. 1997. Antitumor effect of murine colon carcinoma cells retrovirally transduced with interleukin-4 and granulocyte macrophage-colony stimulating factor. Oncology 54:69.
49. Tasaki, K., Y. Gunji, H. Matsubara, K. Takenaga, T. Suzuki, T. Asano, T. Ochiai, K. Isono, T. Kouzu, S. Sakiyama, and M. Tagawa. 1998. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine carcinoma cells. Anticancer Res. 18:1455.
50. Smyth, M. J., D. I. Godfrey, and J. A. Trapani. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2:293.
51. Allavena, P., G. Bianchi, C. Paganin, G. Giardina, and A. Mantovani. 1996. Regulation of adhesion and transendothelial migration of natural killer cells. Nat. Immun. 15:107.
52. Ford, J. G., D. Rennick, D. D. Donaldsod, R. Venkayya, C. McArthur, E. Hansell, V. P. Kump, M. Warnock, and G. Grunig. 2001. IL-13 and IFN-γ: interactions in lung inflammation. J. Immunol. 167:1769.
53. Vesterinen, E., and T. Timonen. 1988. Natural killer cell activity in specific and non-specific bronch challenge. Ann. Allergy 60:247.
54. Korsgren, M., C. G. Persson, F. Sundler, T. Bjerke, T. Hansson, B. J. Chambers, S. Hong, L. Van Kaer, H. G. Ljunggren, and O. Korsgran. 1999. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189:553.
55. Knight, S. C., and P. A. Bedford. 2001. Dendritic cell/dendritic cell interaction. In Dendritic Cells: Biology and Clinical Application, 2nd Ed. M. T. Lotze and A. W. Thomson, eds. Academic Press, New York.
56. MacDonald, A. S., and E. Pearce. 2002. Cutting edge: polarized Th cell response induction by transferred antigen-pulsed dendritic cells is dependent on IL-4 and IL-12 production by recipient cells. J. Immunol. 168:3122.
57. Loza, M. J., and B. Perussia. 2001. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2:917.
58. Loza, M. I., L. Zamai, L. Azzoni, E. Rosati, and B. Perussia. 2002. Expression of type 1 (interferon γ) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99:1273.
59. + natural killer cells and regulation of their pool size by IL-4. Eur. J. Immunol. 32:413.
60. Bonecchi, R., S. Sozzani, J. T. Stine, W. Luini, G. D'Amico, P. Allavena, D. Chantry, and A. Mantovani. 1998. Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 92:2668.
61. Sjolin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195:825.
62. Andrews, D. M., A. A. Scalzo, W. M. Yokoyama, M. J. Smyth, and M. A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4:175.
63. Huard, B., M. Toumier, and F. Triebel. 1998. LAG-3 does not define a specific mode of natural killing in human. Immunol. Lett. 61:109.